ALDH2 Antibody

What is ALDH2 and what cellular functions does it perform?

ALDH2 (Aldehyde Dehydrogenase 2) is a mitochondrial enzyme that plays a crucial role in detoxifying aldehydes by converting them into less toxic acids. This function is vital for cellular health and metabolism. ALDH2 is particularly important in alcohol metabolism, where it converts toxic acetaldehyde, a byproduct of alcohol metabolism, into non-toxic acetate. Beyond alcohol metabolism, ALDH2 participates in retinoic acid biosynthesis, which regulates gene expression essential for embryonic development and cellular differentiation . ALDH2 also plays a significant role in the detoxification of reactive oxygen species (ROS) and metabolism of other aldehydes, serving a protective function against oxidative stress .

What types of ALDH2 antibodies are available for research applications?

ALDH2 antibodies are available in multiple formats tailored to different experimental needs:

Researchers should select antibodies based on their specific experimental requirements, target species reactivity (human, mouse, rat), and application methods .

How does ALDH2 expression vary across different tissue types?

ALDH2 expression shows distinct tissue-specific patterns that are important to consider when designing experiments:

• Highest expression is found in the liver, where it plays a critical role in alcohol metabolism

• Expressed in the brain, particularly in frontal and temporal cortices, mid-brain, and hippocampus, primarily in glial cells and neuropils

• Detected in kidney tissues as demonstrated by immunohistochemistry

• Present in heart tissue

• Found in various cancer cell lines, including HepG2 (liver cancer), A549 (lung cancer), and SK-BR-3 (breast cancer) cells, while showing lower expression in MCF-7 breast cancer cells

Understanding this expression pattern is crucial for experimental design and interpretation, especially when using ALDH2 as a biomarker or therapeutic target .

What are the optimal protocols for using ALDH2 antibodies in Western blot applications?

For Western blot detection of ALDH2, follow these methodological guidelines:

Sample Preparation:

• Use appropriate extraction buffers for the cellular compartment (ALDH2 is mitochondrial)

• Recommended protein amount: 20-30 μg of total protein per lane

• Include liver tissue lysates as positive controls (human, mouse, or rat depending on your experiment)

Protocol Recommendations:

• Run samples on 10-15% SDS-PAGE gel

• Expected molecular weight: 56 kDa (may appear as 50-55 kDa band)

• Recommended antibody dilutions:

  • For monoclonal antibodies: 1:500-1:2000

  • For polyclonal antibodies: 1:5000-1:50000

• Blocker: 5% non-fat dry milk or BSA in TBST

• Secondary antibody: HRP-conjugated anti-mouse/rabbit IgG

• Detection: Standard ECL or other chemiluminescent systems

Validation Controls:

• Multiple tissue types (liver, heart, kidney) should be tested when establishing the protocol

• Negative controls without primary antibody

• Comparison with different ALDH2 antibody clones is recommended for validation

What are the critical considerations for immunohistochemistry with ALDH2 antibodies?

Successful immunohistochemical detection of ALDH2 requires careful attention to the following methodological aspects:

Antigen Retrieval:

• Heat-induced epitope retrieval is essential for paraffin-embedded sections

• Recommended methods: TE buffer (pH 9.0) or citrate buffer (pH 6.0)

• Antigen Retrieval Reagent-Basic has been validated for some antibodies

Antibody Incubation Parameters:

• Primary antibody dilutions: 1:50-1:500 for polyclonal , 1:200-1:1000 for monoclonal

• Incubation time: Overnight at 4°C or 1-3 hours at room temperature

• Secondary detection systems: HRP polymer-based detection systems show good results

• Visualization: DAB (brown) with hematoxylin counterstain (blue)

Expected Staining Pattern:

• Cytoplasmic staining pattern (consistent with mitochondrial localization)

• Strong expression in hepatocytes and renal tubular cells

• Variable expression across different tissue types

Validation Controls:

• Include normal liver tissue as positive control

• Include sections without primary antibody as negative controls

• Comparison with other cell markers may help validate specificity

How should researchers optimize ALDH2 antibody concentration for different experimental applications?

Optimization of antibody concentration is critical for obtaining reliable and reproducible results. Follow this systematic approach:

For Western Blot:

• Begin with a broad titration range (e.g., 1:500, 1:1000, 1:5000, 1:10000)

• Select samples with known high ALDH2 expression (e.g., liver tissue)

• Evaluate signal-to-noise ratio at each dilution

• For polyclonal antibodies, higher dilutions (1:5000-1:50000) may be effective

• For monoclonal antibodies, lower dilutions (1:500-1:2000) are typically optimal

For Immunohistochemistry:

• Start with manufacturer's recommended range (typically 1:50-1:500)

• Perform a dilution series on known positive tissue

• Assess specific staining versus background at each concentration

• Optimal conditions should show clear cytoplasmic staining with minimal background

For Immunofluorescence:

• Begin with intermediate dilutions (1:150-1:500)

• Test multiple fixation protocols (4% paraformaldehyde is commonly effective)

• Include nuclear counterstain (DAPI) to assess cellular localization

• Recommended working range: 1:150 for monoclonal and 1:500-1:1000 for polyclonal

Always validate results by comparing with literature reports and different antibody clones when possible.

How can ALDH2 antibodies be used to investigate the relationship between ALDH2 expression and cancer progression?

Research has revealed important connections between ALDH2 expression and cancer, particularly hepatocellular carcinoma (HCC). Here's a methodological approach for investigating this relationship:

Experimental Design Strategy:

• Tissue Microarray Analysis:

  • Compare ALDH2 expression in tumor tissues versus adjacent normal tissues

  • Correlate with clinicopathological parameters (grade, stage, survival)

  • Research indicates ALDH2 is significantly down-regulated in HCC compared to normal liver tissue

• Prognostic Value Assessment:

  • Stratify patients based on ALDH2 expression levels

  • Perform Kaplan-Meier survival analysis

  • Studies show high ALDH2 expression correlates with better prognosis in HCC (OS: HR=0.42, 95% CI 0.29-0.6, P=1.3e-06)

• Mechanism Investigation:

  • Examine correlation with immune infiltration markers

  • ALDH2 expression has been linked to dendritic cells and macrophages in immune infiltration

  • Investigate metabolic pathway alterations using functional enrichment analysis

  • Data indicates ALDH2 is associated with multiple metabolic processes and valine/leucine/isoleucine degradation pathways

• Nomogram Construction:

  • Combine ALDH2 expression with clinical factors to develop prognostic nomograms

  • Evaluate using ROC curve analysis (reported AUC of 0.925)

This approach allows for comprehensive evaluation of ALDH2's role in cancer progression and potential utility as a prognostic biomarker.

What methodologies can be used to study ALDH2 genetic variations and their impact on enzyme function?

ALDH2 genetic variations, particularly the ALDH2*2 variant common in East Asian populations, significantly impact enzyme function. Here's a comprehensive approach to studying these variations:

Methodological Framework:

• Genotyping Approaches:

  • PCR-RFLP analysis targeting known SNPs (particularly Glu504Lys causing ALDH2*2)

  • Sanger sequencing of the ALDH2 gene

  • Next-generation sequencing for comprehensive variant detection

• Functional Enzyme Assays:

  • Spectrophotometric measurement of ALDH2 activity in tissue samples

  • Kinetic analysis comparing wild-type and variant enzymes

  • Determination of acetaldehyde metabolism rates

• Protein Structure-Function Analysis:

  • Western blot analysis to compare protein expression levels between genotypes

  • Immunoprecipitation to assess enzyme complex formation

  • Co-immunoprecipitation to study protein-protein interactions affected by genetic variants

• Cellular and Animal Models:

  • Comparison of ALDH2-WT and ALDH2-KO mice responses to alcohol exposure

  • Cell culture models expressing different ALDH2 variants

  • Studies show ALDH2-KO mice display greater sensitivity to alcohol-induced damage

• Clinical Correlation:

  • Associate genotypes with clinical phenotypes (facial flushing, alcohol sensitivity)

  • The ALDH2*2 variant is associated with increased risk for Alzheimer's disease and certain cancers

This methodological approach enables comprehensive understanding of how genetic variations impact ALDH2 function and disease susceptibility.

How can ALDH2 antibodies be applied in neurodegenerative disease research?

ALDH2 has emerging roles in neuroprotection and neurodegenerative diseases. Here's a methodological framework for investigating these connections:

Research Strategy:

• Brain Region-Specific Expression Analysis:

  • Immunohistochemistry to map ALDH2 expression across brain regions

  • ALDH2 is expressed in frontal and temporal cortices, mid-brain, and hippocampus

  • Compare expression patterns between normal and disease states

• Neuroprotective Mechanism Investigation:

  • Measure lipid peroxidation markers (4-HNE, MDA, acrolein) in relation to ALDH2 levels

  • Assess oxidative stress parameters (3-nitrotyrosine) in neuronal models

  • Evaluate mitochondrial function in relation to ALDH2 activity

• Alzheimer's Disease Models:

  • Compare ALDH2 expression in AD versus control brain tissues

  • Investigate ALDH2 interaction with AD pathology markers (Aβ, tau)

  • Studies indicate ALDH2 deficiency increases risk for late-onset Alzheimer's disease

• Parkinson's Disease Applications:

  • Examine ALDH2 levels in substantia nigra of PD models

  • Investigate correlation with dopaminergic neuron loss

  • Research suggests ALDH2 has neuroprotective effects against PD

• Therapeutic Target Validation:

  • Use ALDH2 antibodies to monitor changes in expression following interventions

  • Validate ALDH2 activators as potential neuroprotective agents

  • Correlate ALDH2 activity with behavioral and cognitive outcomes

This approach facilitates comprehensive investigation of ALDH2's role in neurodegeneration and potential therapeutic applications.

What are the common challenges in ALDH2 antibody specificity and how can they be addressed?

Researchers often encounter specificity issues with ALDH2 antibodies due to homology with other ALDH family members. Here's a methodological approach to address these challenges:

Problem Identification and Solutions:

• Cross-reactivity with ALDH1:

  • Challenge: ALDH1 and ALDH2 share significant sequence homology

  • Solution: Select antibodies that target unique epitopes between AA 317-517 of human ALDH2

  • Validation: Compare staining patterns between cytosolic (ALDH1) and mitochondrial (ALDH2) markers

• Varying band patterns in Western blots:

  • Challenge: Observed molecular weight may range from 50-56 kDa

  • Solution: Include positive control samples (liver tissue) with known ALDH2 expression

  • Validation: Perform parallel blots with different ALDH2 antibody clones

• Background staining in IHC/IF:

  • Challenge: Non-specific binding, particularly in tissues with high endogenous peroxidase

  • Solution: Optimize blocking (5-10% serum from secondary antibody species)

  • Validation: Include sections without primary antibody as negative controls

• Species-specific considerations:

  • Challenge: Variable epitope conservation across species

  • Solution: Select antibodies validated for your species of interest (human, mouse, rat)

  • Validation: Test antibody on samples from multiple species in parallel

• Methodological validation approaches:

  • Knockdown/knockout controls: Test antibody specificity using ALDH2-KO samples

  • Peptide competition assays: Pre-incubation with immunizing peptide should abolish specific signal

  • Orthogonal methods: Confirm results using different detection techniques (e.g., mass spectrometry)

These approaches significantly improve confidence in ALDH2 antibody specificity and experimental results.

How should researchers interpret contradictory results between different ALDH2 antibodies or detection methods?

Contradictory results with different ALDH2 antibodies are not uncommon. Here's a systematic approach to reconcile discrepancies:

Methodological Investigation Framework:

• Antibody Characteristics Analysis:

  • Compare epitope regions: Different epitopes may be differentially accessible in native proteins

  • Evaluate antibody types: Monoclonal (higher specificity) vs. polyclonal (broader epitope recognition)

  • Review validation data: Check if antibodies were validated in knockout/knockdown systems

• Technical Variables Assessment:

  • Fixation methods: Different fixatives may mask or expose different epitopes

  • Sample preparation: Denaturing (Western blot) vs. native conditions (IF) affect epitope accessibility

  • Detection systems: Sensitivity differences between DAB, fluorescence, or chemiluminescence

• Biological Variable Consideration:

  • Post-translational modifications: May affect epitope recognition

  • Splice variants: Different antibodies may recognize different isoforms

  • Subcellular localization: Confirm mitochondrial localization using appropriate markers

• Resolution Strategy:

  • Orthogonal validation: Confirm results using non-antibody methods (e.g., mRNA expression)

  • Multiple antibody approach: Use at least two antibodies targeting different epitopes

  • Functional validation: Correlate protein detection with enzymatic activity measurements

  • Literature corroboration: Compare with published results using the same antibodies

This systematic approach helps researchers interpret contradictory results and determine the most reliable findings.

What are the key considerations for quantifying ALDH2 expression across different experimental systems?

Accurate quantification of ALDH2 requires careful methodological considerations to ensure comparability across different experimental systems:

Standardization Framework:

• Western Blot Quantification:

  • Loading controls: Use mitochondrial markers (VDAC, COX IV) rather than whole-cell markers (β-actin, GAPDH)

  • Normalization approach: Always normalize ALDH2 band intensity to loading control

  • Standard curves: Include concentration gradients of positive control samples

  • Dynamic range: Ensure detection is within linear range of signal intensity

• IHC/IF Quantification:

  • Scoring systems: Develop consistent scoring methods (H-score, Allred score)

  • Digital pathology: Use software-based quantification for objective assessment

  • Controls: Include calibration standards on each slide/batch

  • Batch effects: Process all comparative samples simultaneously

• Flow Cytometry Considerations:

  • Gating strategy: Establish consistent gating based on negative controls

  • Fluorescence minus one (FMO) controls: Essential for accurate positive population identification

  • Mean fluorescence intensity (MFI): More informative than percent positive cells for expression levels

• Cross-Platform Comparison:

  • Relative vs. absolute quantification: Be consistent in reporting methods

  • Reference standards: Include common samples across different experimental platforms

  • Meta-analysis approach: Use rank-based statistics when combining data from different platforms

• Biological Variables:

  • Tissue/cell heterogeneity: Consider single-cell approaches for heterogeneous samples

  • Genetic variants: Account for ALDH2 polymorphisms that may affect antibody binding or protein levels

  • Experimental conditions: Document all variables that may affect ALDH2 expression (treatments, stress conditions)

This comprehensive approach enables reliable quantification and comparison of ALDH2 expression across diverse experimental systems.

How can ALDH2 antibodies be utilized in investigating the role of ALDH2 in immune cell infiltration and cancer immunotherapy?

Recent research has revealed unexpected connections between ALDH2 and tumor immune microenvironment. Here's a methodological framework to investigate this emerging area:

Research Approach:

• Multiplex Immunophenotyping:

  • Co-staining of ALDH2 with immune cell markers (CD4, CD8, CD68, CD11c)

  • Research indicates ALDH2 is correlated with dendritic cells and macrophages in immune infiltration

  • Multiplex immunofluorescence or mass cytometry for comprehensive immune profiling

• Spatial Analysis in Tumor Microenvironment:

  • Analyze spatial relationships between ALDH2+ cells and immune infiltrates

  • Digital pathology algorithms to quantify co-localization patterns

  • Correlation with prognostic outcomes and treatment response

• Functional Immune Response Assessment:

  • ALDH2 expression in antigen-presenting cells and effect on T cell activation

  • Impact of ALDH2 activity on cytokine production and immune cell metabolism

  • Potential role in regulating oxidative stress in immune cells

• Immunotherapy Response Prediction:

  • Correlation between ALDH2 expression and response to immune checkpoint inhibitors

  • Development of ALDH2-based biomarker panels for immunotherapy stratification

  • Impact of ALDH2 genetic variants on immunotherapy outcomes

• Therapeutic Targeting Approaches:

  • ALDH2 modulators as potential adjuvants to enhance immunotherapy

  • Combination strategies targeting ALDH2 and immune checkpoints

  • Cell-type specific ALDH2 modulation in immune cells versus tumor cells

This innovative approach explores ALDH2's emerging role in cancer immunology and potential applications in immunotherapy.

What are the latest methodologies for investigating ALDH2's role in protecting against formaldehyde-induced DNA damage?

Emerging research highlights ALDH2's critical role in preventing formaldehyde-induced DNA damage. Here's a cutting-edge methodological framework:

Advanced Research Strategy:

• DNA-Protein Crosslink (DPC) Analysis:

  • Quantify formaldehyde-induced DPCs using mass spectrometry

  • Compare DPC formation between ALDH2-proficient and ALDH2-deficient systems

  • Correlation with ALDH2 enzymatic activity and expression levels

• Integration with DNA Repair Pathways:

  • Investigate ALDH2 interaction with Fanconi anemia proteins

  • Research indicates ALDH2 deficiency creates dependency on Fanconi anemia proteins in leukemia

  • Co-immunoprecipitation and proximity ligation assays to detect protein-protein interactions

• Genomic Integrity Assessment:

  • Measure chromosomal aberrations in relation to ALDH2 activity

  • γH2AX foci quantification as marker of DNA double-strand breaks

  • Single-cell genome sequencing to detect mutation patterns

• Developmental and Reproductive Implications:

  • Maternal-fetal transfer of aldehydes and protective role of ALDH2

  • Research shows maternal aldehyde elimination preserves fetal genome integrity

  • Immunohistochemical analysis of ALDH2 in placental tissues

• Therapeutic Intervention Strategies:

  • ALDH2 activators as genome-protective agents

  • Combination approaches targeting aldehyde sources and detoxification

  • Monitoring intervention efficacy using DNA damage biomarkers

This approach enables comprehensive investigation of ALDH2's genome-protective functions with implications for cancer prevention, reproductive health, and genotoxicity risk assessment.

How can researchers effectively study the interactions between ALDH2 and other proteins in signaling pathways?

Investigating ALDH2's interactions with other proteins requires sophisticated methodological approaches:

Advanced Interaction Analysis Framework:

• Proximity-Based Interaction Detection:

  • Proximity ligation assay (PLA) to visualize protein interactions in situ

  • BioID or APEX2 proximity labeling to identify interacting proteins in living cells

  • Förster resonance energy transfer (FRET) for real-time interaction dynamics

• Co-Immunoprecipitation Strategy:

  • Optimize lysis conditions to preserve mitochondrial protein interactions

  • Published protocols demonstrate successful ALDH2 co-immunoprecipitation

  • Mass spectrometry analysis of immunoprecipitated complexes for unbiased interaction discovery

• Post-Translational Modification Analysis:

  • Investigate ALDH2 acetylation, succinylation, and phosphorylation

  • Research indicates SIRT5-mediated desuccinylation of ALDH2 alleviates oxidative stress

  • Antibodies against modified forms of ALDH2 or mass spectrometry approaches

• Pathway Integration Analysis:

  • AMPK and LDLR pathway interactions with ALDH2 in foam cell formation

  • Investigate cross-talk between ALDH2 and mitochondrial quality control pathways

  • Systems biology approaches to model ALDH2 in cellular signaling networks

• Advanced Imaging Approaches:

  • Super-resolution microscopy to visualize ALDH2 complexes within mitochondria

  • Live-cell imaging with fluorescently tagged ALDH2 to track dynamic interactions

  • Correlative light and electron microscopy for ultrastructural context

This comprehensive approach enables detailed characterization of ALDH2's protein interactions and signaling roles with implications for understanding its diverse biological functions.